EFFICACY OF CORONARY STENTING AND BASIC PHARMACOTHERAPY IN ELDERLY AND SENILE PATIENTS: THE RESULTS OF LONG-TERM PROSPECTIVE FOLLOW-UP
https://doi.org/10.20996/1819-6446-2011-7-6-708-712
Abstract
Aim. To compare survival rate and quality of life in geriatric patients after coronary stenting or after basic pharmacotherapy only. Material and methods. 135 patients of geriatric age with ischemic heart disease (IHD) were included into the study. Coronary stenting with the subsequent basic pharmacotherapy was carried out in 70 patients, other 65 patients received basic pharmacotherapy only. Additional examinations (echocardiography , coronaroventriculography , treadmill test) were performed during the 12 months follow-up for indications other than standard clinical and laboratory examinations. Total mortality and myocardial infarction rate, quality of life indices, and instrumental ex- aminations data were analyzed. Results. During one year after coronary stenting the overall mortality risk reduced in 3.3% and risk of non-fatal myocardial re-infarction decreased in 2.0%. Besides significant reduction in hospitalization rate, clinical improvement in stable angina course, increase in coronary heart reserve were observed in patients after PCI in comparison with these in patients received only standard pharmacotherapy. At the end of follow-up according to echocardiography data patients undergone coronary stenting shown increase in the left ventricle ejection faction (from 47.5±6.65% to 52.2±4.27%; р<0.010). This was not observed in patients with pharmacotherapy only (from 48.3±6.40% to 49.1±5.86%). Conclusion. Coronary stenting in geriatric IHD patients is an effective method of treatment. It increases quality of life due to reduction in the hospitalization rate and improves clinical course of stable angina.
References
1. Fletcher R.W., Fletcher S.W., Wagner E.H. Clinical epidemiology. 3 Sub ed. Philadelphia: Lippincott Williams & Wilkins; 1996.
2. Grinhal'h T. Fundamentals of Evidence-Based Medicine. Moscow: GEOTAR-Media; 2006. Russian (Гринхальх Т. Основы доказательной медицины М.: ГЭОТАР-Медиа; 2006).
3. Guidelines on the management of stable angina pectoris. The Task Force the management of stable angina pectoris of the European Society of Cardiology Eur Heart J 2006; 27 Suppl 11; 1391-1398.
4. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31: 2501–2555.
5. Katritsis G., Siontis G.C., Kastrati A. Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes. Eur Heart J 2011; 32: 32–40.
6. Expert Consensus Document on the use of antiplatelet agents. The Task Force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. Eur Heart J 2004; 25: 166–81.
7. Rebrova O.Ju. Statistical analysis of medical data. Application software package STATISTICA. M.:Mediasfera; 2004. Russian (Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. М.:Медиа-сфера; 2004).
8. Spertus J.A., Winder J.A., Dewhurst T.A. et al. Development and evaluation of Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995;78:333-341.
9. Pepine C.J., Bourassa M.G., Chaitman B.R. et al. Factors influencing clinical outcomes after revascularization in the asymptomatic cardiac ischemia pilot (ACIP). ACIP Study Group. J Card Surg 1999;14(1):1-8.
10. Henderson R.A., Pocock S.J., Clayton T.C. et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003; 42: 1161-1170.
11. Pfisterer M; Trial of Invasive versus Medical therapy in Elderly patients Investigators. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation 2004;110(10):1213-8.
12. Boden W.E., O'rourke R.A., Teo K.K. et al. The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. Am J Cardiol 2007;99(2):208-12.
13. Min S.Y., Park D.W., Yun S.C. Major predictors of long-term clinical outcomes after coronary revascularization in patients with unprotected left main coronary disease: analysis from the MAIN-COMPARE study. Circ Cardiovasc Interv 2010; 3: 127–133.
14. Long-Term Comparison of Drug-Eluting Stents and Coronary Artery Bypass Grafting for Multivessel Coronary Revascularization: 5-Year Outcomes From the Asan Medical Center-Multivessel Revascularization Registry. J Am Coll Cardiol 2011; 57: 128-137.
Review
For citations:
Mirzakhanova L.R. EFFICACY OF CORONARY STENTING AND BASIC PHARMACOTHERAPY IN ELDERLY AND SENILE PATIENTS: THE RESULTS OF LONG-TERM PROSPECTIVE FOLLOW-UP. Rational Pharmacotherapy in Cardiology. 2011;7(6):708-712. (In Russ.) https://doi.org/10.20996/1819-6446-2011-7-6-708-712
Views: 494
Email this article 